IR情報

2017/05/29~2017/10/19

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2017
10/248:30 2017年12月期第3四半期決算短信〔米国基準〕(連結)
10/19711719701710-2.2%160,400249億5903万+1.14%
10/1815:30 四半期報告書の提出期限延長に関する書面の提出のお知らせ
10/18739741716726-0.27%100,600255億2148万+4.16%
10/17750754728728-3.58%138,500255億9179万+5.35%
10/16751758738755+1.21%131,400265億4094万+10.06%
10/13746760736746+2.33%211,400262億2456万+9.87%
10/12720742720729+2.1%196,800256億2694万+8.48%
10/11726731711714-0.7%108,300250億9964万+7.37%
10/10718720704719-0.96%136,000252億7541万+8.94%
10/06712744687726+1.82%325,800255億2148万+10.84%
10/05775777682713-8.12%617,600250億6449万+9.69%
10/04775783766776+0.39%299,400272億7916万+20.31%
10/03750773745773+3.76%399,700271億7370万+21.16%
10/038:00 有価証券の募集に係る発行登録の承認に関するお知らせ
10/0215:30 従業員株式購入プランの実施(新株発行)に関するお知らせ
10/02736745730745+2.34%271,200261億8940万+18.07%
09/29720735705728-0.27%163,300255億9179万+16.67%
09/28733739717730+2.24%162,100256億6210万+18.12%
09/27698716696714+1.42%165,800250億9964万+16.86%
09/26711740686704-3.16%540,300247億4811万+16.36%
09/25702728690727+7.39%537,400255億5664万+21.37%
09/22642685642677+7.63%446,600237億9896万+14.36%
09/21629632602629+1.62%180,100221億1159万+6.97%
09/20639639619619-0.48%276,600217億750万+5.99%
09/1919:00 MN-166のメタンフェタミン(覚醒剤)依存症を適応とするフェーズ2臨床治験の患者登録完了のお知らせ
09/19619624612622+2.3%83,200218億1270万+7.06%
09/15610625588608-3.49%229,300213億2174万+5.74%
09/14593633590630+6.06%320,100220億9325万+10.33%
09/13596600593594-0.17%75,000208億3078万+4.76%
09/12586596584595+1.71%49,400208億6585万+5.5%
09/11584590580585-0.17%39,200205億1516万+4.09%
09/08584589579586+0.34%46,800205億5023万+4.46%
09/07589593579584+4.1%60,300204億8009万+4.29%
09/06543576543561-1.06%61,000196億7351万+0.18%
09/05591594562567-3.9%61,000198億8393万+1.25%
09/04591597589590-1.17%36,800206億9051万+5.36%
09/01592600592597-0.5%30,400209億3599万+6.61%
08/31599600591600+1.01%53,100210億4119万+7.14%
08/30596597589594-0.17%25,600208億3078万+6.26%
08/29587595580595+0.34%38,600208億6585万+6.44%
08/28585595584593+3.13%116,100207億9571万+5.89%
08/25575583563575+0.7%118,800201億6448万+2.68%
08/24563571555571+0.88%45,600200億2420万+1.96%
08/23558573558566+1.98%73,600198億4886万+1.07%
08/22551562546555+0.18%40,300194億6310万-1.07%
08/21560565551554-1.07%58,900194億2803万-1.42%
08/18536562530560+0.36%76,500196億1043万-0.53%
08/17554562553558+1.45%44,800195億4040万-1.06%
08/16539558525550+3.97%94,600192億6025万-2.65%
08/15492529492529+8.85%112,000185億2486万-6.54%
08/14495498480486-3.76%149,400170億1905万-14.44%
08/10518518497505-2.51%145,400176億8441万-11.71%
08/09525526513518-2.08%85,400181億3965万-10.07%
08/08531531517529-2.22%122,100185億2486万-8.48%
08/07556556540541-3.91%105,400189億4508万-6.88%
08/04559563558563-0.71%44,900197億1549万-3.43%
08/03569570560567-1.05%81,000198億5556万-2.91%
08/02572576571573+0.53%24,200200億6568万-2.22%
08/01583583570570-0.52%92,000199億6062万-2.9%
07/31585585571573-1.38%74,300200億6568万-2.55%
07/28580583577581-0.85%42,200203億4582万-1.53%
07/2710:00 2017年12月期第2四半期決算説明会資料
07/27583588581586-0.85%49,900205億2092万-0.85%
07/278:30 2017年12月期第2四半期決算短信〔米国基準〕(連結)
07/26590594586591-0.84%27,700206億9601万0%
07/25600600591596-0.67%35,900208億7110万+0.85%
07/24599601593600+0.33%30,600210億1118万+1.35%
07/21586599578598+3.82%111,500209億4114万+1.01%
07/20580581575576-0.69%57,800199億3491万-2.7%
07/1915:30 四半期報告書の提出期限延長に関する書面の提出のお知らせ
07/19580580578580-0.85%15,100200億7334万-2.19%
07/18581588580585-0.51%19,900202億4639万-1.52%
07/14580588579588+1.73%49,700203億5022万-1.34%
07/13580583578578-0.34%42,000200億412万-3.18%
07/125845845785800%28,500200億7334万-3.17%
07/115825865805800%48,900200億7334万-3.49%
07/10575580572580+0.35%53,500200億7334万-3.81%
07/07589589573578-1.53%64,500200億412万-4.62%
07/06585593585587-0.51%24,900203億1561万-3.77%
07/05590596578590-0.17%94,900204億1944万-3.75%
07/04595597585591-0.34%33,000204億5404万-4.06%
07/03595597582593-1%55,500205億2326万-4.2%
06/30586600578599+2.04%96,900207億3092万-3.7%
06/29598602587587-2%103,500203億1561万-6.08%
06/28600603598599-0.5%50,000207億3092万-4.62%
06/27601608600602-0.17%70,900208億3475万-4.75%
06/26610610602603-1.31%33,800208億6936万-4.89%
06/23608612606611+0.16%115,600211億4623万-3.78%
06/22603610599610+1.84%121,200211億1162万-4.09%
06/21598603595599+0.34%67,600207億3092万-5.97%
06/20599602597597-0.67%123,500206億2065万-6.57%
06/19604607599601-0.5%120,100207億5881万-6.24%
06/1615:30 平成29年12月期第2四半期決算発表および決算説明会のお知らせ
06/166006095996040%153,900208億6243万-5.92%
06/156046086006040%86,300208億6243万-6.21%
06/14607613601604-0.49%204,000208億6243万-6.36%
06/1310:00 株式の立会外分売終了に関するお知らせ
06/13602612601607-2.25%344,300209億6605万-5.89%
06/1216:00 株式の立会外分売実施に関するお知らせ
06/12632632616621+0.32%40,200214億4962万-4.02%
06/0915:30 ストックオプション(新株予約権)の発行に関するお知らせ
06/09618620612619-0.8%66,800213億8054万-4.48%
06/099:00 定時株主総会の決議に関するお知らせ
06/086276286206240%25,800215億5324万-3.85%
06/07630635622624-2.35%68,300215億5324万-4%
06/06649653639639-4.2%114,700220億7134万-1.84%
06/068:00 米国腫瘍学会2017年次総会におけるMN-166のグリオブラストーマ(神経膠芽腫)動物モデルスタディに関する発表要旨のお知らせ
06/0515:30 株式の立会外分売に関するお知らせ
06/05672672665667-0.15%42,300230億3848万+2.46%
06/02663669663668+0.45%43,100230億7302万+2.61%
06/01656670656665+0.76%45,200229億6940万+2.47%
05/31660667657660-1.05%61,200227億9669万+2.01%
05/30667691655667+0.15%94,000230億3848万+3.25%
05/29669687660666-0.15%77,300230億394万+3.26%